Course Description

*This selection is for the Final Exam only. Access to the book, Clinical Textbook of Addictive Disorders (Fourth Edition), is required to complete the exam. To order the e-Book from Guilford Press (which enables you to take the course immediately), click here. To order the paperback book from PRP, click here. 

This program presents a comprehensive discussion of the assessment and treatment of all the major addictive disorders, including alcohol, nicotine, opioids, cannabis, hallucinogens and inhalants, caffeine, stimulants, cocaine, and sedatives/hypnotics and benzodiazepines.  Polysubstance use, abuse, and dependence, and co-occuring substance use disorders are examined as well as gambling and other behavioral addictions. Special populations in which substance use and abuse occur such as older adults, HIV/AIDS patients, women, and adolescent, are addressed. Psychotherapeutic and psychopharmacologic treatment methods for the addictive disorders are presented.

25 CE credits/hours, 250 questions

Target Audience

Psychologists | School Psychologists | Marriage & Family Therapists | Mental Health Counselors | Social Workers

Learning Level

Intermediate

Learning Objectives

  • Discuss the foundations of addiction historically and neurobiologically.
  • Apply diagnostic criteria to the assessment of substance users and abusers.
  • Compare different laboratory testing procedures.
  • Analyze the difference between substances of abuse.
  • Identify polysubstance use, abuse, and dependency.
  • Identify behavioral addictions.
  • Examine addiction in the workplace.
  • Assess chronic pain patients who misuse opioids.
  • Apply special considerations to older adult substance abuse.
  • Apply special considerations to women substance abusers.
  • Apply special considerations to adolescent substance users and abusers.
  • Utilize matching and differential therapies for the most appropriate treatment.
  • Design treatments using individual psychodynamic psychotherapy.
  • Design treatments using cognitive therapy.
  • Utilize group therapy methods.
  • Apply motivational interviewing techniques to substance abuse clients.
  • Blend psychopharmacological treatments with psychotherapy.

Sections

  1. 1

    • Statement of Understanding (downloadable/printable)
  2. 2

    • Final Exam Questions (downloadable/printable)

    • Final Exam
  3. 3

    • Evaluation Questionnaire

About the Editors

Avram H. Mack, MD

Avram H. Mack, MD, is Associate Chair for Quality and Safety at the Children’s Hospital of Philadelphia, where he is a practicing psychiatrist with a focus on substance use disorders and forensic, child, adult, and consultation–liaison psychiatry. Dr. Mack leads efforts on quality and patient safety and has had extensive experience as a teacher and administrator in undergraduate and graduate medical education for trainees and staff at the University of Pennsylvania, the Children’s Hospital of Philadelphia, and previously at Georgetown University. He is board-certified in general psychiatry, child and adolescent psychiatry, forensic psychiatry, and addiction medicine and presents, publishes, and testifies extensively regarding substance abuse. A past president of the Washington Psychiatric Society, he served on the board of directors of the American Psychiatric Association and on the Impaired Physicians Committee of the Medical Society of the District of Columbia. A distinguished Fellow of the American Psychiatric Association and a Fellow of the American College of Psychiatrists, Dr. Mack is a recipient of the Education Award presented by the Association for Academic Psychiatry in recognition of his efforts in advancing the patient safety movement within psychiatry.

Kathleen T. Brady, MD, PhD

Kathleen T. Brady, MD, PhD, is Distinguished University Professor and Associate Provost for Clinical and Translational Science at the Medical University of South Carolina. Her interests include drug and alcohol abuse/addiction and comorbid conditions. A board-certified psychiatrist, Dr. Brady leads numerous research projects and served as president of the American Academy of Addiction Psychiatry, a member of the Scientific Advisory Council of the National Institute on Drug Abuse, and a board member of the College on Problems of Drug Dependence. She has authored over 300 publications; presented at conferences, grand rounds, and symposia; and received numerous awards.

Sheldon I. Miller, MD

Sheldon I. Miller, MD, until his death in 2011, was Emeritus Professor of Psychiatry and former Chairman of the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. Recognized as a national leader in addiction psychiatry, he was a cofounder of the American Academy of Addiction Psychiatry. Dr. Miller was the author of more than 100 publications and Editor-in-Chief of the American Journal on Addictions. He served on the Board of Directors of the Accreditation Council for Graduate Medical Education and the American Board of Emergency Medicine and was a Distinguished Fellow of the American Psychiatric Association and a member of the Group for the Advancement of Psychiatry.